The Enterprise Value as of December 2025 (TTM) for BioMark Diagnostics Inc. (BUX.CN) is 50.07M

According to BioMark Diagnostics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 50.07M. This represents a change of 109.50% compared to the average of 23.90M of the last 4 quarters.

BioMark Diagnostics Inc. (BUX.CN) Historical Enterprise Value (quarterly & annually)

How has BUX.CN Enterprise Value performed in the past?

The mean historical Enterprise Value of BioMark Diagnostics Inc. over the last ten years is 14.63M. The current 50.07M Enterprise Value has changed 34.12% with respect to the historical average. Over the past ten years (40 quarters), BUX.CN's Enterprise Value was at its highest in in the June 2025 quarter at 33.78M. The Enterprise Value was at its lowest in in the December 2018 quarter at 3.80M.

BioMark Diagnostics Inc. (BUX.CN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BioMark Diagnostics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioMark Diagnostics Inc. (BUX.CN) Average Enterprise Value

How has BUX.CN Enterprise Value performed in the past?

The current Enterprise Value of BioMark Diagnostics Inc. (BUX.CN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BioMark Diagnostics Inc. (BUX.CN) Enterprise Value vs. Peers

How is BUX.CN’s Enterprise Value compared to its peers?

BioMark Diagnostics Inc.’s Enterprise Value is greater than Izotropic Corporation (22.81M), greater than DIAGNOS Inc. (35.99M), greater than Avicanna Inc. (26.93M), greater than Microbix Biosystems Inc. (27.97M), greater than Rubicon Organics Inc. (33.47M), greater than MediPharm Labs Corp. (17.53M), less than Charlotte's Web Holdings, Inc. (64.29M), greater than Perimeter Medical Imaging AI, Inc. (14.19M), greater than Voyageur Pharmaceuticals Ltd. (26.43M), greater than Gemina Laboratories Ltd. (17.07M),

Build a custom stock screener for BioMark Diagnostics Inc. (BUX.CN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioMark Diagnostics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioMark Diagnostics Inc. (BUX.CN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioMark Diagnostics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.